-Significant reduction in plasma glucose levels during OGTT after treatment with Canagliflozin (minute 30: 161.5 ± 36.22 vs. 215.9 ± 58.11 mg/dl; minute 60: 187.46 ± 65.88 vs. 225.9 ± 85.60 mg/dl, p < 0.01).-Significant decrease in insulin levels during OGTT (minute 30: 95.6 ± 27.31 vs. 216.35 ± 94.86 mg/dl, p = 0.03; minute 60: 120.85 ± 94.86 vs. 342.64 ± 113.32 mIU/L, p < 0.001).—85.7% reduction in the rate of hypoglycemia at minute 180 (p < 0.00001). Here, INS is linked to Hypoglycemia.